Exploring chatbot applications in pancreatic disease treatment: potential and pitfalls
Rattachement africain : it, ca. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Aim : The use of chatbots to respond across various domains is becoming more integrated into daily life, potentially replacing traditional search engines. The study aimed to investigate the performance of different large language models (LLMs) in providing recommendations regarding pancreatic cancer (PC) to surgeons. Methods : Standardized prompts were engineered to query four freely accessible LLMs (ChatGPT-4, Personal Intelligence by Inflection AI, Anthropic Claude 3 Haiku Version 3.5, Perplexity AI) on October 9th, 2024. Fourteen questions included the incidence, diagnosis, and treatment for radiologically resectable, borderline resectable, locally advanced, and metastatic PC. Three different investigators queried the LLMS simultaneously. The reliability and accuracy of the responses were evaluated using a 4-point Likert scale and then compared to the international guidelines. Descriptive statistics were used to report outcomes as counts and percentages. Results : Overall, 72% of the responses were deemed correct (scored 3 or 4). Claude provided the most accurate responses (32%), followed by ChatGPT (28%). ChatGPT-4 and Anthropic Claude 3 Haiku Version 3.5 achieved the overall highest score rate (4-point) at 50% and 52%, respectively. Regarding the quality and accuracy of the responses, ChatGPT cited guidelines most frequently (29%). However, only 19% of all evaluated responses included guideline citations. Conclusion : The LLMs are still not suitable for safe, standalone use in the medical field, but their rapid learning capabilities suggest they may become indispensable tools for medical professionals in the future.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Exploring chatbot applications in pancreatic disease treatment: potential and pitfalls
- Date Crossref
- 28/07/2025
- Éditeur
- OAE Publishing Inc.
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Casa di Cura Villa Garda pays non établi dans la noticeÉtablissement de santé
-
Pancreas Centre (Canada) pays non établi dans la noticeEntreprise
-
University of Verona Hospital Trust Department of General and Pancreatic Surgery pays non établi dans la noticeUniversité ou école supérieure
-
Pederzoli Hospital General Surgery Unit pays non établi dans la noticeÉtablissement de santé
Casa di Cura Villa Garda, Pancreas Centre (Canada) et Department of General and Pancreatic Surgery — University of Verona Hospital Trust, avec 1 autre affiliation.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.